Biotechnologiepark Luckenwalde GmbH Company Profile

01:19 EDT 25th March 2018 | BioPortfolio

The Biotechnology Park Luckenwalde lies about 30 miles south from the Berlin city centre. The excellent connections to roads, rail and to the Berlin airports ensures easy accessibility. The 22.000 inhabitants of the district town of the district of Teltow-Flaeming offers an excellent infrastructure in education, healthcare, culture and living conditions as ideal basic frame work. In the 70 acre park-like area new and established biotechnical firms come together under unrivalled conditions. The concept of the project guarantees a direct proximity of research working and living functions in a delightful recreational countryside, which is rich in water and forest.

The Biotechnology Park Luckenwalde serves the development of small and medium sized biotechnological firms, their suppliers and their service providers. The project offers both new founded and outsourced and already existing companies the best conditions in the Berlin/Potsdam area. This focus makes the location, even for large firms in the branch, very interesting. Groupings of this type are capable of generating synergies of high quality and effectiveness.

Conceptually the park integrates the following functional areas on a campus:

Incubator Technology and Innovation Center
Building Moduls
Industrial sites
Co-operation network with R & D


Im Biotechnologiepark, TGZ


Phone: 49 33 71 / 6 81-1 00
Fax: 49 33 71 / 6 81-1 05

News Articles [120 Associated News Articles listed on BioPortfolio]

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

NexWafe GmbH schließt Finanzierung in Höhe von 8 Millionen Euro ab

NexWafe GmbH, ein Spin-off des Fraunhofer ISE, das eine bahnbrechende Technologie zur epitaktischen Herstellung von Siliziumwafern für Photovoltaik kommerzialisiert, gab heute den Abschluss einer F...

Gerresheimer-Aktie: Dividendenerhöhung auch für 2018? Kaufempfehlung

Frankfurt am Main - Gerresheimer-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, nehmen in einer aktuellen Aktienanalyse die Coverage....

Original-Research: PHARMING (von First Berlin Equity Research GmbH): BUY

Original-Research: PHARMING - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu PHARMING Unternehmen: PHARMING ISIN: NL0010391025 Anlass der Studie: Update ...

Original-Research: Valneva (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva Unternehmen: Valneva ISIN: FR0004056851 Anlass der Studie: 9M/17-Erge...

Evotec-Aktie: Q3/17 operativ beeindruckend - mehr Innovationen - Kaufen! Aktienanalyse

Frankfurt am Main - Evotec-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse weiterhin zum Kauf ....

DGAP-News: Vara Research GmbH: QIAGEN Q4 2017 Consensus Estimates (deutsch)

Vara Research GmbH: QIAGEN Q4 2017 Consensus Estimates DGAP-News: Vara Research GmbH / Schlagwort(e): Sonstiges Vara Research GmbH: QIAGEN Q4 2017 Consensus Estimates 25.01.2018 / 11:16 Für den In...

Original-Research: Mologen AG (von First Berlin Equity Research GmbH): BUY

Original-Research: Mologen AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Mologen AG Unternehmen: Mologen AG ISIN: DE0006637200 Anlass der Studie: Q...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [42 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [528 Associated Companies listed on BioPortfolio]

Biotechnologiepark Luckenwalde GmbH

The Biotechnology Park Luckenwalde lies about 30 miles south from the Berlin city centre. The excellent connections to roads, rail and to the Berlin airports ensures easy accessibility. The 22.000 inh...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Biotechnologiepark Luckenwalde GmbH" on BioPortfolio

We have published hundreds of Biotechnologiepark Luckenwalde GmbH news stories on BioPortfolio along with dozens of Biotechnologiepark Luckenwalde GmbH Clinical Trials and PubMed Articles about Biotechnologiepark Luckenwalde GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotechnologiepark Luckenwalde GmbH Companies in our database. You can also find out about relevant Biotechnologiepark Luckenwalde GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record